Clinical trial
Acute Promyelocytic Leukemia 2006 (APL)
NCT00378365 · Assistance Publique - Hôpitaux de Paris, Other · Unknown status
Key facts
| NCT number | NCT00378365 |
|---|---|
| Title | Acute Promyelocytic Leukemia 2006 (APL) |
| Official title | A Randomized Trial Assessing the Role of Arsenic Trioxide and/or ATRA During Consolidation Course in Newly Diagnosed Acute Promyelocytic Leukemia (APL) |
| Lead sponsor | Assistance Publique - Hôpitaux de Paris, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Leukemia, Promyelocytic, Acute |
| Intervention type | Procedure |
| Interventions | Arsenic trioxide, ATRA |
| Enrollment | 800 |
| Start date | Oct 1, 2006 |
| Primary completion | Sep 1, 2016 |
| Completion | Sep 1, 2016 |
| First posted | Sep 20, 2006 |
| Last update posted | Apr 16, 2014 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: